Skip to content
World clockEU--:--UK--:--USA--:--CN--:--PLDEFRIT中文EN

portal about AI and technologyevents · analysis · interviews · technical background

Search
LIVE
›

Anthropic's 'AI discovery' claim draws biologist backlash as MIT Tech Review questions the bar

Anthropic said its molecular biology lab made its first AI-assisted discovery. Biologists pushed back hard, and MIT Technology Review reported on 29 September that the claim may set the wrong bar for what counts as science.

ScienceNewsSofia MarchettiPublished: 29 September 20265 min readSources 4
Anthropic's 'AI discovery' claim draws biologist backlash as MIT Tech Review questions the bar

Last Wednesday, Anthropic announced that it had launched a molecular biology lab earlier this year. There, Claude agents read and conjecture about hard biology problems. Human scientists then run experiments on what they report. According to MIT Technology Review, the company said the lab had made its first discovery. The claim did not land well.

The system of 950 agents worked for 21 hours. What it found was not a brand-new DNA sequence. The agents flagged a repeating pattern surrounding a known enzyme. Anthropic said the pattern had not been catalogued before. MIT Technology Review, in a piece published on 28 September and republished in The Algorithm newsletter, noted how Anthropic described it. The announcement calls the pattern “reminiscent” of what led to CRISPR, the gene-editing technology that “has already transformed science and medicine.” That framing is where the trouble starts.

Biologists say finding the pattern was the easy part

A viral post from a biologist drew support from the chair and CEO of the drugmaker Eli Lilly. The post argued that “finding a weird cluster of genes and repeats is often the easy part. The hard part, and where the real discoveries come from, is figuring out what the system actually does.” MIT Technology Review reported that the agents helped with some laboratory grunt work. According to that critique, a discovery it is not.

Muddying things further, Mario Rodríguez Mestre, a biologist at the University of Copenhagen, said over the weekend that his team had already discovered this particular pattern. The New York Times reported the claim, according to MIT Technology Review. Mestre regularly chatted with Claude in his work. He wondered whether Anthropic's team had learned from his conversations. Anthropic denies this, but Mestre says he is stopping all use of Claude anyway. The dispute matters beyond one company's press release. MIT Technology Review argued that AI companies do not present their systems simply as tools scientists can use, like microscopes or supercomputers. Instead, they insist the systems are making discoveries themselves. To some biologists, that is incompatible with how science actually works. New knowledge more typically emerges from collaboration and an ever-growing arsenal of tools.

The math problem next door

The pattern is not unique to biology. MIT Technology Review noted that earlier this month OpenAI said its own team agents had cracked a million-dollar problem in mathematics. A couple of weeks later, nearly every AI skeptic in the writer's feed was sharing an article. It asked whether it was the math problem that really mattered. The piece did not argue OpenAI's solution was wrong. It argued only that the particular result may not be the one mathematicians care most about. A mathematician also accused the models of using some of his work without credit. People are left thinking either OpenAI cheated or the solution was not important anyway.

Lucas Harrington, the biologist who wrote the post critiquing Anthropic's announcement, closed with a suggestion. AI companies, he said, should “set the bar high now, so that when an AI actually discovers a fundamentally new biological mechanism, everyone appreciates how big a deal it is.” MIT Technology Review noted that raising the bar might be the last thing on the minds of OpenAI's Sam Altman and Anthropic's Dario Amodei. They are racing to one-up each other.

Real results, different questions

Elsewhere the science is less contested. A paper submitted to arXiv on 15 September and posted to the preprint server reports the first direct detection of auroral radio emission from an exoplanet. The planet is the giant β Pictoris b, and the detection used the MeerKAT array. The authors, Kevin N. Ortiz Ceballos, Edo Berger and Yvette Cendes, report rapid, recurring, highly circularly polarized bursts. They also report persistent emission at frequencies of 0.85 to 3.5 GHz. They identify the emission as electron cyclotron maser radiation. That implies a magnetic field of at least 1.25 kG at the planet, the first such direct field strength measurement for an exoplanet. The paper is 32 pages with nine figures and three tables.

In medicine, a study published in Cell Reports describes a molecular mechanism. It may explain why lost weight so often returns. Researchers at the Harrington Discovery Institute at University Hospitals and Case Western Reserve University found that obesity altered the activity of fat cells. That change kept asprosin elevated after weight loss. Asprosin is a hormone released by fat tissue that signals the brain to stimulate appetite. The work centers on TGF-β1, an inflammatory signaling molecule. Brief exposure to it created a lasting epigenetic change that remained for weeks after TGF-β1 levels returned to normal. Even when mice shed all their excess weight, their fat cells continued producing more asprosin.

“It was like flipping a light switch that stays on even after you remove your finger,” said Atul Chopra, MD, PhD, senior author of the study and associate director of the Harrington Rare Disease Program at Harrington Discovery Institute at UH. “Even after mice lost all the excess weight and TGF-β1 returned to normal, this switch in their fat cells remained flipped, keeping asprosin and appetite elevated. This gives us a molecular explanation for why GLP-1 drugs, which suppress appetite while you take them, cannot fix the underlying biological memory that drives hunger back up once treatment ends.”

Scitech Daily, which reported the findings on 28 September, noted that evidence from publicly available human datasets supported the proposed mechanism. Researchers must still confirm directly that it operates the same way in people. A separate laboratory led by Seth J. Field, MD, PhD, confirmed that the cellular change persisted.

What to watch

MIT Technology Review will publish its 2026 list of Climate Tech Companies to Watch on 6 October. The package covers energy storage, nuclear power and transportation. The newsletter also flagged that OpenAI has scrapped a new AI model, GPT-6.1 Astra, over safety concerns. The company said it “didn't quite meet the bar,” according to BBC. Anthropic's IPO filing warns that AI could threaten humanity, the FT reported.

For now, the disagreement over Anthropic's enzyme pattern is unresolved. The company denies that its system learned from Mestre's Claude conversations. Mestre says he has stopped using Claude. And the broader question remains open: does an AI flagging a pattern in a mass of biological data count as a discovery?

Comments 0

Sources

4
  1. 01The Download: climate tech companies to watch and AI's discovery problemEN
  2. 02When can we say AI made a scientific discovery?EN
  3. 03Scientists Discover a Molecular "Memory" That Could Make Lost Weight Come BackEN
  4. 04Discovery of radio emission from the exoplanet β Pictoris bEN

All figures and quotations in this text come from the sources listed below.

Content prepared by the editorial team with AI assistance.

Sofia Marchetti

Sofia Marchetti

Science and health

Sofia Marchetti covers science and health for FLASH24, working from primary literature, preprints, and agency data rather than press releases. She checks sample sizes, confidence intervals, and whether a study's numbers match its abstract before filing. She interviews researchers and clinicians directly, tracks conference calendars for embargoed results, and compares new findings with earlier trials on the same question. Outside the newsroom she works on materials physics and stargazes through a home telescope, which keeps her close to how measurement error actually behaves. She does not publish a health claim without a named source and the underlying data.

Newsroom →

Comments

0
  1. No comments yet — be the first.

Write a comment

Comments are public. We do not publish abuse, spam or advertising.